CompoAtlas

Eye Improvement

Natural health product licensed in Canada

Licence holder
Red Maple Bio Inc.
NPN or DIN-HM
80095293
Status
Active licence
Licence date
8 November 2019
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
N-éthyl-L-glutamine

Source : L-Théanine

100 mgNot calculated
Zinc

Source : Zinc

8 mg8,000 µg
Vitamine D

Source : Cholécalciférol

15 mcg15 µg

Non-medicinal ingredients

Gélatine, Dioxyde de silicium, Cellulose microcristalline, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
Adultesminimum: 19 years1 Capsule1 Tous les jours

Uses authorised in Canada

Source of vitamins and minerals, factors in the maintenance of good health. Source of vitamins and minerals, factors in normal growth and development. Source of vitamins and minerals to support biological functions which play a key role in the maintenance of good health. Helps to maintain eyesight and support eye health in conditions (associated with sunlight damage), such as cataracts and age-related macular degeneration. Source of antioxidant that protect cell against the oxidative damage caused by free radicals. Helps to maintain immune function.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80095293

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line